Stem cell factor

Leo Lacerna, William P. Sheridan, Russell Basser, C. Glenn Begley, Jeffrey Crawford, George Demetri, Craig Moskowitz, Guido Tricot, Andrew Weaver, John A. Glaspy

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

I. INTRODUCTION Efforts to understand mutations in inbred laboratory mice leading to abnormalities of coat color, hematopoiesis, and fertility began 4 decades ago and were ultimately explained after the characterization of stem cell factor (SCF) and its receptor, c-kit. The history, biochemistry, and preclinical biology of SCF have been described in an extensive review by Galli et al. (1) and elsewhere (2-6). (Note that reviews are frequently cited as references; reviews are indicated as such at the end of their citations in the reference list.) The purpose of this chapter is to focus on clinical studies of patients undergoing transplantation of hematopoietic peripheral blood progenitor cells (PBPCs), and to relate these recent observations to preclinical findings and relevant clinical questions: Will SCF, when combined with filgrastim [granulocyte colony-stimulating factor (G-CSF)], be useful in PBPC transplantation? Will the combination mobilize increased numbers of PBPCs and improve the yield of leukapheresis? Will this facilitate multiple cycles of high-dose chemotherapy? Will SCF/filgrastim-mobilized PBPCs shorten the time to engraftment? Will adding SCF to filgrastim increase the number of patients who are candidates for PBPC transplantation?.

Original languageEnglish (US)
Title of host publicationHematopoietic Stem Cell Transplantation
PublisherCRC Press
Pages31-46
Number of pages16
ISBN (Electronic)9780824741815
ISBN (Print)9780824702731
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Stem Cell Factor
Blood Cells
Stem Cells
Cell Transplantation
Proto-Oncogene Proteins c-kit
Leukapheresis
Hematopoiesis
Granulocyte Colony-Stimulating Factor
Biochemistry
Fertility
Color
Transplantation
History
Drug Therapy
Mutation
Filgrastim

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lacerna, L., Sheridan, W. P., Basser, R., Glenn Begley, C., Crawford, J., Demetri, G., ... Glaspy, J. A. (2000). Stem cell factor. In Hematopoietic Stem Cell Transplantation (pp. 31-46). CRC Press.

Stem cell factor. / Lacerna, Leo; Sheridan, William P.; Basser, Russell; Glenn Begley, C.; Crawford, Jeffrey; Demetri, George; Moskowitz, Craig; Tricot, Guido; Weaver, Andrew; Glaspy, John A.

Hematopoietic Stem Cell Transplantation. CRC Press, 2000. p. 31-46.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lacerna, L, Sheridan, WP, Basser, R, Glenn Begley, C, Crawford, J, Demetri, G, Moskowitz, C, Tricot, G, Weaver, A & Glaspy, JA 2000, Stem cell factor. in Hematopoietic Stem Cell Transplantation. CRC Press, pp. 31-46.
Lacerna L, Sheridan WP, Basser R, Glenn Begley C, Crawford J, Demetri G et al. Stem cell factor. In Hematopoietic Stem Cell Transplantation. CRC Press. 2000. p. 31-46
Lacerna, Leo ; Sheridan, William P. ; Basser, Russell ; Glenn Begley, C. ; Crawford, Jeffrey ; Demetri, George ; Moskowitz, Craig ; Tricot, Guido ; Weaver, Andrew ; Glaspy, John A. / Stem cell factor. Hematopoietic Stem Cell Transplantation. CRC Press, 2000. pp. 31-46
@inbook{c7953381a5c742ea80a3397a9c16a653,
title = "Stem cell factor",
abstract = "I. INTRODUCTION Efforts to understand mutations in inbred laboratory mice leading to abnormalities of coat color, hematopoiesis, and fertility began 4 decades ago and were ultimately explained after the characterization of stem cell factor (SCF) and its receptor, c-kit. The history, biochemistry, and preclinical biology of SCF have been described in an extensive review by Galli et al. (1) and elsewhere (2-6). (Note that reviews are frequently cited as references; reviews are indicated as such at the end of their citations in the reference list.) The purpose of this chapter is to focus on clinical studies of patients undergoing transplantation of hematopoietic peripheral blood progenitor cells (PBPCs), and to relate these recent observations to preclinical findings and relevant clinical questions: Will SCF, when combined with filgrastim [granulocyte colony-stimulating factor (G-CSF)], be useful in PBPC transplantation? Will the combination mobilize increased numbers of PBPCs and improve the yield of leukapheresis? Will this facilitate multiple cycles of high-dose chemotherapy? Will SCF/filgrastim-mobilized PBPCs shorten the time to engraftment? Will adding SCF to filgrastim increase the number of patients who are candidates for PBPC transplantation?.",
author = "Leo Lacerna and Sheridan, {William P.} and Russell Basser and {Glenn Begley}, C. and Jeffrey Crawford and George Demetri and Craig Moskowitz and Guido Tricot and Andrew Weaver and Glaspy, {John A.}",
year = "2000",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780824702731",
pages = "31--46",
booktitle = "Hematopoietic Stem Cell Transplantation",
publisher = "CRC Press",

}

TY - CHAP

T1 - Stem cell factor

AU - Lacerna, Leo

AU - Sheridan, William P.

AU - Basser, Russell

AU - Glenn Begley, C.

AU - Crawford, Jeffrey

AU - Demetri, George

AU - Moskowitz, Craig

AU - Tricot, Guido

AU - Weaver, Andrew

AU - Glaspy, John A.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - I. INTRODUCTION Efforts to understand mutations in inbred laboratory mice leading to abnormalities of coat color, hematopoiesis, and fertility began 4 decades ago and were ultimately explained after the characterization of stem cell factor (SCF) and its receptor, c-kit. The history, biochemistry, and preclinical biology of SCF have been described in an extensive review by Galli et al. (1) and elsewhere (2-6). (Note that reviews are frequently cited as references; reviews are indicated as such at the end of their citations in the reference list.) The purpose of this chapter is to focus on clinical studies of patients undergoing transplantation of hematopoietic peripheral blood progenitor cells (PBPCs), and to relate these recent observations to preclinical findings and relevant clinical questions: Will SCF, when combined with filgrastim [granulocyte colony-stimulating factor (G-CSF)], be useful in PBPC transplantation? Will the combination mobilize increased numbers of PBPCs and improve the yield of leukapheresis? Will this facilitate multiple cycles of high-dose chemotherapy? Will SCF/filgrastim-mobilized PBPCs shorten the time to engraftment? Will adding SCF to filgrastim increase the number of patients who are candidates for PBPC transplantation?.

AB - I. INTRODUCTION Efforts to understand mutations in inbred laboratory mice leading to abnormalities of coat color, hematopoiesis, and fertility began 4 decades ago and were ultimately explained after the characterization of stem cell factor (SCF) and its receptor, c-kit. The history, biochemistry, and preclinical biology of SCF have been described in an extensive review by Galli et al. (1) and elsewhere (2-6). (Note that reviews are frequently cited as references; reviews are indicated as such at the end of their citations in the reference list.) The purpose of this chapter is to focus on clinical studies of patients undergoing transplantation of hematopoietic peripheral blood progenitor cells (PBPCs), and to relate these recent observations to preclinical findings and relevant clinical questions: Will SCF, when combined with filgrastim [granulocyte colony-stimulating factor (G-CSF)], be useful in PBPC transplantation? Will the combination mobilize increased numbers of PBPCs and improve the yield of leukapheresis? Will this facilitate multiple cycles of high-dose chemotherapy? Will SCF/filgrastim-mobilized PBPCs shorten the time to engraftment? Will adding SCF to filgrastim increase the number of patients who are candidates for PBPC transplantation?.

UR - http://www.scopus.com/inward/record.url?scp=78349241823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349241823&partnerID=8YFLogxK

M3 - Chapter

SN - 9780824702731

SP - 31

EP - 46

BT - Hematopoietic Stem Cell Transplantation

PB - CRC Press

ER -